New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis

Eichenfield Lawrence F.; Tanghetti Emil A.; Guenin Eric; Martin Gina; Pillai Radhakrishnan

首页> 外文期刊>Journal of drugs in dermatology: JDD >New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis

【24h】

New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis

机译：新的聚合物一次每日达拉替烯0.045％乳液配方中度至严重痤疮：合并第3阶段儿科分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Acne vulgaris affects approximately 85% of adolescents. Topical tazarotene is efficacious and safe for acne treatment but irritation limits its use. The objective was to evaluate efficacy, safety, and tolerability of a new tazarotene 0.045% lotion formulation in patients aged 10-13 and 14-17 years with moderate-to-severe acne.

机译：背景：寻常痤疮影响大约85％的青少年。局部塔拉塔罗琳对于痤疮治疗有效和安全，但刺激限制了其使用。目的是评估新的塔拉替烯0.045％乳液配方的疗效，安全性和耐药性，以2-13岁和14-17岁，中度至严重的痤疮。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2020年第6期|共9页
作者
Eichenfield Lawrence F.; Tanghetti Emil A.; Guenin Eric; Martin Gina; Pillai Radhakrishnan;
展开▼
作者单位

Univ Calif San Diego Sch Med Dept Dermatol San Diego CA 92103 USA;

Ctr Dermatol &

Laser Surg Sacramento CA USA;

Ortho Dermatol Bridgewater MA USA;

Bausch Hlth US LLC Petaluma CA USA;

Bausch Hlth US LLC Petaluma CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
专利

1. New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis [J] . Eichenfield Lawrence F., Tanghetti Emil A., Guenin Eric, Journal of drugs in dermatology: JDD . 2020,第6期

机译：新的聚合物一次每日达拉替烯0.045％乳液配方中度至严重痤疮：合并第3阶段儿科分析
2. Novel Polymeric Lotion Formulation of Once-Daily Tazarotene (0.045%) for Moderate-to-Severe Acne: Pooled Phase 3 Analysis [J] . Tanghetti Emil A., Werschler William Philip, Lain Edward, Journal of drugs in dermatology: JDD . 2020,第3期

机译：正常达拉替烯（0.045％）的新型聚合物乳液制剂用于中度至严重的痤疮：合并相3分析
3. Once-Daily Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Sex [J] . Kircik Leon H., Gold Linda Stein, Beer Kenneth, Journal of drugs in dermatology: JDD . 2020,第8期

机译：每日每日聚合物达拉唑丁酮0.045％洗剂中度至严重的痤疮：汇集阶段3按性别分析
4. An Improved Unified Viscoplastic Polymer Constitutive Formulation for Multiscale Analysis of Polymer Matrix Composites Under High Strain Rate Loading [C] . Christopher Sorini, Aditi Chattopadhyay, Robert K. Goldberg AIAA SciTech forum and exposition . 2019

机译：用于高应变率载荷下聚合物基复合材料多尺度分析的改进的统一粘塑性聚合物组成配方
5. Heterophase polymerization of acrylamide and quarternary ammonium comonomers: Formulation, prediction and control [D] . Ni, Huafang 1996

机译：丙烯酰胺和季铵单体的异相聚合：配方，预测和控制
6. Tazarotene 0.045 Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis [O] . Hilary E. Baldwin, Lawrence J. Green, Leon Kircik, 2021

机译：TaZarotene在男性和女性参与者中适中对严重痤疮的0.045％乳液：HOC分析后II期

New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis

摘要

著录项

相似文献

相关主题

期刊订阅